Krishan Ramdoo is the CEO and Founder of Tympahealth technologies. He has developed the world’s first all-in-one ear and hearing health assessment system. It brings together three different diagnostic and treatment systems into one. It combines a digital otoscope, microsuction wax removal and a hearing screener into a single, hand-held, portable device delivered by trained allied health professionals.Dr. Ramdoo started his Medical career in 2009 and after initially working in the Oxford University hospitals he went on to be an Ear, Nose and Throat surgeon in London before embarking on his PhD at UCL, where his area of interest became the impact of hearing loss globally.
In 2023, TympaHealth raised $23M in Series A funding led by Octopus Ventures.

Patrik is a clinician scientist with a research portfolio focused in digital health implementation science. He is an NHS doctor in Acute Internal Medicine and Venture Partner supporting the first NHS-backed VC fund.
Patrik was previously the UK’s first clinical research fellow in Digital Health, completing a PhD supervised by Professor Nicholas Peters through funding from Imperial Health Charity and NIHR. He completed his academic foundation training (laboratory sciences) at University College London; award-winning MSc research at Barts and The London School of Medicine; and Core Medical Training at King’s College Hospital. He was subsequently the recipient of a prestigious Harvard Knox Fellowship, the preeminent scholarship for UK citizens pursuing postgraduate study at Harvard University. He completed his Masters in Public Health (MPH, health policy and digital health concentration) while cross-registered at the Massachusetts Institute for Technology (MIT), Kennedy School of Government, and Harvard Medical and Business Schools. HIs practicum was supervised by Dr. Trishan Panch at Wellframe, which provides digital health management to tens of millions of patients in the US.

Originally qualified as a Chartered Accountant with PricewaterhouseCoopers, where she advised health and social care clients such as GSK, Roche and Aventis; Anna has previously held number of senior NHS regional commercial and improvement roles, including Commercial Programme Director at the London Commercial Support Unit.
Anna joined HIN in 2013, and since then her focus has been on building relationships between the NHS and industry. A founder of DigitalHealth.London, she also developed the DigitalHealth.London Accelerator Programme.

Chloe is Investor Relationships Manager of CPI Enterprises, based in London to expand the deep tech investor community, and to engage with academia and SMEs to explore potential investment and partnership opportunities.
Prior to joining CPI, Chloe has 9 years significant experience of the early-stage investment ecosystem. She was partner at China's first and largest Entrepreneurship educational platform and incubator before co-founding a US-China-based micro-VC and accelerator, which she later exited successfully. She then launched the UK entity of a family office and CVC, G5 Capital before joining CPI in 2022. Chloe started her career in media and consulting. She holds an MBA from Imperial College Business School and a MSc in Financial Journalism from City University London.

One of the UK’s first Clinical Research Fellows in Digital Health with clinical training in Cardiology and Internal Medicine (ST5). Mihir works with a team of clinicians, data scientists, engineers, policymakers and patients to address patient and health system priorities. Extensive collaborations with early stage ventures and big tech, operating at the intersection of clinical AI and MedTech innovation and regulation, commercial considerations, pathway development and generation of real-world clinical and health economic evidence to implement scalable, better and more cost-effective care.

Eileen Tanghal is a trailblazing Filipina-American engineer, entrepreneur, and venture capitalist with a rich history in the tech industry. Beginning her career as a device physicist at a successful early-stage semiconductor company, she quickly made her mark in the field. Her journey includes pivotal roles, notably leading venture capital groups at Applied Materials and ARM, and serving as a Senior Partner then Managing Director at In-Q-Tel in London, where she directed investments in significant tech startups such as Cerebras and Mythic.
In 2022, Eileen co-founded Black Opal Ventures with Dr. Tara Bishop, targeting the intersection of hard tech and healthcare innovation with a $62M fund. Beyond her VC activities, Eileen is deeply involved in education and empowerment, operating theCoderSchool Fremont with her husband and serving on the board of Notre Dame High School in San Jose, CA. Her commitment extends to promoting women's presence in STEM and venture capital, demonstrating her passion for both technological advancement and inclusivity.

Francisco is the CEO and founder of Bowhead health, a digital health platform which aims to empower people to own and control their health data. It enables users to safely and easily share self-reported health behaviours and symptom survey data with researchers. He previously founded Revenue.com, a native advertising technology, as well as Titan Gaming (acquired, now Playsino) with over 14 million users in his dorm room at McGill University. Titan launched the first fully automated cash tournament system for online games in 2008. He is a Forbes 30 under 30 recipient.

Christian is co-head of private credit at Blackrock. He founded DiaMonTech, an award-winning medical technology start-up pioneering non-invasive blood glucose measurements. In 2022, they completed a $5 million investment round, bringing its total funding to over $20 million. Samsung Ventures is also one of its strategic partners. DiaMonTech’s goal is to globally provide people living with diabetes with a ground-breaking technology for managing blood glucose levels without finger pricking, needles and test strips. The patented mid-infrared technology enables non-invasive blood glucose measurement using a pain-free laser-based detection that is as easy to use as the fingerprint sensor on a smartphone. He holds an MBA from LBS.

Guilhem worked at Bayer for over 20 years, holding various positions. He led the strategic planning process for over thirty products and projects for a €3.6b business unit at Bayer, which involved corporate strategy, marketing and R&D among others. His position as head of Bayer's specialty medicine business in Greece enabled him to apply his learning points from his MBA at LBS, where he was fully accountable for multiple product launches and business strategies. As VP head of business strategy and operations, he dealt with organisational transformation and change management while cultivating the « intrapreneurial » mindset in emerging markets. As Business Unit Head for Cardiovascular and Women Health, he went back to single country operations, and with challenges relevant to bigger organisations and established markets. He is now transitioning towards an entrepreneurial career and has founded a med tech business.

Rhydian is a current LBS MBA. He brings years of health tech start up experience to the health tech challenge. He originally trained as a doctor, working in A&E, but pivoted to health tech to address the widespread problem of antiquated processes and technology getting in the way of good clinical care. Having held a number of operator roles across the product and clinical functions at several London based start- and scale-ups, he most recently launched BiteLabs, an educational programme providing healthcare professionals with the necessary skills to build impactful careers in health tech. He also mentors on Zinc’s venture accelerator.

Born in Bangladesh, Yaasha Hasan (MBA2022) immigrated to the US as a teenager, where her family hoped to make a better life for themselves. After much success in the retail world - and a life-altering health experience in her personal life - the Laidlaw scholar has embarked on a new chapter in her career. Today, she finds herself at the cutting edge of AI and fulfilling an early passion for healthcare, after her MBA at LBS. She is Global Commercial and Product Marketing Lead at Scalpel AI, an artificial intelligence-powered digital platform designed to provide end-to-end patient safety during surgeries. The company's platform detects, predicts, and prevents human factor-related errors at different points within the surgical care pathway, enabling surgeons to be more accurate.

Lucie currently works as a Senior Innovation Advisor within the Strategy Directorate at Imperial College Health Partners. In her current role she supports on the planning and delivery of improvement and innovation programmes to improve health outcomes for the population of North West London. Prior to this, she has 6 years experience of medical and older persons physiotherapy in acute hospital settings. In 2020, she completed an Improvement and Innovation Fellowship at Chelsea and Westminster Hospital NHS Foundation Trust.
Following this, I took on a lead physiotherapist role for medicine and frailty at West Middlesex University Hospital. During this time she completed a master's module in Dementia Management and Care at Buckinghamshire New University.

Gerard started his career with 10 years in the pharmaceutical industry, initially with Chugai Pharmaceutical (now part of Roche) in Japan, then with Glaxo (now GSK) in the UK. He then worked for 15 years in investment banking across three continents, focusing on healthcare M&A. He then started his own business, GGS Associates, which provides executive search and investor introductions. He has raised capital for a number of companies internationally. He is an investor in companies across various sectors, and a mentor and judge at MassChallenge, Cleantech Challenge and MedTech SuperConnector. He is also an Innovate UK Assessor.

Anushka is an experienced healthcare leader and strategist with a demonstrated history working in product innovation and commercial strategy across the pharmaceutical, health and medical devices sector. She is an LBS EMBA Alumni. Prior to consulting, Anushka qualified as a medical doctor and practiced for 6 years across US and UK Health Systems. She has a strong scientific background accompanied by professional qualifications in a breadth of areas including Digital Strategy and Leadership, Value Based Healthcare and Marketing Analytics. She has advised a variety of health related start-ups on their journey to commercialisation- and is most invigorated by this sort of work. She is also an Expert Advisor to UN (CEFACT) for Artificial Intelligence and Blockchain in Healthcare.

After a Masters in Neuroscience and 7 years as a surgical trainee in the UK, Louise made a career switch and joined RYSE, one of Europe's leading healthcare investors with a ground-breaking approach to selecting and rapidly scaling innovative early-stage companies. They have partnerships with the largest health-tech accelerator in Europe, Novartis, Medtronic, and the NHS. Also she is an LBS MBA Alumni.

Aaron is the co-founder and COO of Mindstep as well as a qualified medical doctor. Mindstep is creating a new care standard for cognitive health by providing AI-driven neurodiagnostics, screening for risk factors of the most prevalent brain conditions, and comprehensive interventions. Mindstep has received funding from Octopus Ventures, Calm/Storm Ventures and The Capital Partnership. Prior to founding Mindstep Aaron held pivotal positions in various capacities: serving as an NHS vaccinator, an NHS Clinical Entrepreneur, an Executive Director at the American Academy of Medicine and Surgery, and as Assistant Executive Director at Stanford University School of Medicine.

Jessica is co-founder & CXO of SomX, a healthtech and biotech-specific communications group. She is also an executive editor and regular host for Healthtech Pigeon, a news brand rounding up the sector's news. Previously an Associate Director at global agency, FleishmanHillard, Jessica has extensive experience across the healthcare ecosystem from the NHS, industry, Royal Colleges and charities, as well as in consumer health, healthtech, medical devices and pharmaceuticals. She specialises in building and leading teams to design and deliver purpose-driven, integrated and targeted communications strategies that support companies on a mission to solve healthcare's biggest challenges.

James is the co-founder of SomX, an agency specializing in health tech communications. He edits the engaging Healthtech Pigeon newsletter and podcast and hosts The Healthtech Podcast with an international audience. A contributor for Forbes, James covers health tech, startups, and innovation. His healthcare background spans working in anesthetics and ICU, policy involvement with NHS England, and leading the DigitalHealth.London Accelerator. He founded HS. Ventures to invest in deep tech and holds degrees in medicine, biomedical sciences, and education, also lecturing globally on health tech entrepreneurship.